"Knowing that we have the extra space to expand in the future is a strategic initiative that has always been important to Tessy," President Roland Beck said in the release. "Having the extra square footage allows us to on-board programs quickly and continually adapt to our customers ever-changing needs."
Tessy declined to comment on the cost of the investment in an email to Plastics News. The buildings were previously owned by Xerox Holdings Corp.
Two out of the three buildings are vacant and the third will be vacant by 2022, the release said. The injection molder will take official ownership of all three buildings by the end of 2021.
Tessy plans to lease a portion of the area to third party tenants while it uses the rest as warehouse space "with the assumption that the buildings will later turn into full scale production plants," it said.
"In 2016, we were excited to nearly double our total square footage and now we have close to triple that amount totaling close to 3 million square feet in central New York," Beck said.
"Just last year we took on a large medical program that required us to have a manufacturing facility readily available. In just 15 weeks, we transformed a 400,000-sq.-ft. warehouse into a … medical manufacturing facility" to support one of its largest customers amid the pandemic, he said.
Tessy Plastics was the 2000 Plastics News Processor of the Year. The company ranked No. 19 in the current PN survey of North American injection molders, with sales of $445 million.